Ireland· IE-PA-PA0775/006/001

Striverdi Respimat 2.5 microgram inhalation solution

A olodaterol product containing olodaterol, registered in Ireland by Boehringer Ingelheim International GmbH. The same ATC class is registered in 14 of our 19 countries.

ATC R03AC19

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about olodaterolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Olodaterol is registered in 14 of 19 countries.

Countries holding a registration under ATC R03AC19 (olodaterol), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
9 of them publish a price we can compare per daily dose

Search olodaterol products by name

Olodaterol · ATC R03AC19

14 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of olodaterol costs, country by country.

Normalised to the WHO defined daily dose (5 mcg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Olodaterol · price per daily dose (5 mcg)

USD · FX 28 Sept 2026

CH Switzerland$1.64

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Olodaterol
Manufacturer: Boehringer Ingelheim International GmbH
Country: Ireland (IE)
ATC code: R03AC19
ATC class: Olodaterol
Defined daily dose: 5 mcg, Inhal
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA0775/006/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

386 interactions on record for olodaterol.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check olodaterol against other medicines How interaction checks work

Olodaterol · interactions on record

386 records

20 severe
365 moderate
1 minor

Most severe, free to view

PindololC07AA03severe
PropranololC07AA05severe
TimololC07AA06severe
SotalolC07AA07severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Olodaterol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olodaterol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Striverdi Respimat
Belgium · Striverdi Respimat
Bulgaria · Стриверди Респимат
Cyprus · Striverdi Respimat
Czechia · Striverdi Respimat
Germany · Striverdi Respimat
Denmark · Striverdi Respimat
Estonia · Striverdi Respimat
Spain · Striverdi Respimat
Finland · Striverdi Respimat
France · Striverdi Respimat
United Kingdom (Northern Ireland) · Striverdi Respimat
Greece · Striverdi Respimat
Hungary · Striverdi Respimat
Iceland · Striverdi Respimat
Italy · Striverdi Respimat
Liechtenstein · Striverdi Respimat
Lithuania · Striverdi Respimat
Luxembourg · Striverdi Respimat
Latvia · Striverdi Respimat
Malta · Striverdi Respimat
Netherlands · Striverdi Respimat
Norway · Striverdi Respimat
Poland · Striverdi Respimat
Portugal · Striverdi Respimat
Romania · Striverdi Respimat
Sweden · Striverdi Respimat
Slovenia · Striverdi Respimat
Slovakia · Striverdi Respimat

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/42cd0e8d-6363-403c-b97a-3eba2b06dae9
GET /v1/drugs/42cd0e8d-6363-403c-b97a-3eba2b06dae9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Inhalation solution",
  "routes": [
    "Inhalation use"
  ],
  "source": "hpra",
  "atc_all": [
    "R03AC19"
  ],
  "strength": null,
  "pa_number": "PA0775/006/001",
  "substances": [
    "Olodaterol"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "18/10/2013",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about olodaterol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console